相关实验视频
Updated: Jul 5, 2025

06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
10.5K
血液形成中的新陈代谢及其恶性病变
Xiaoyuan Zeng1, Yi-Ping Wang2, Cheuk-Him Man3
1Division of Haematology, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Advances in experimental medicine and biology
|January 16, 2024
概括
造血干细胞 (HSC) 维持血液细胞的生产. 它们的新陈代谢对功能至关重要,可以通过利用恶性细胞中独特的代谢依赖来向治疗血液癌症.
科学领域:
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
- 代谢调节 代谢调节 代谢调节 代谢调节
背景情况:
- 造血干细胞 (HSC) 对于不断生成血细胞和维持平衡至关重要.
- 细胞代谢极大地影响HSC功能,包括表观遗传修饰和细胞周期控制.
- 造血细胞中的恶性转变劫持了代谢途径,推动了不受控制的生长.
研究的目的:
- 探索新陈代谢途径在正常血液形成中的作用.
- 为了研究血液形成性恶性瘤中明显的代谢依赖性.
- 讨论针对血液癌症的代谢向疗法的潜力.
主要方法:
- 对目前关于高细胞代谢的文献进行了综述.
- 在血液形成性癌症中对代谢重编程的分析.
- 讨论针对癌症代谢的治疗策略.
主要成果:
- 代谢途径是HSC功能和维护的重要调节者.
- 造血性恶性瘤表现出独特的代谢脆弱性.
- 代谢失调有助于癌细胞中瘤基因的成.
结论:
- 了解高血小细胞代谢是理解血细胞发育和疾病的关键.
- 针对恶性造血细胞中的特定代谢途径提供了一个有希望的治疗途径.
- 针对新陈代谢的疗法代表了治疗血液癌症的新策略.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Overview of Hematopoiesis
4.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K

